MedPath

NDC 72934- 5010-4 BENZOCAINE 20% / LIDOCAINE 8% / TETRACAINE 4%.

BENZOCAINE 20% / LIDOCAINE 8% / TETRACAINE 4%.

Approved
Approval ID

89164fe3-3802-bc8d-e053-2a95a90aab00

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 17, 2019

Manufacturers
FDA

Sincerus Florida, LLC

DUNS: 080105003

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NDC 72934- 5010-4 BENZOCAINE 20% / LIDOCAINE 8% / TETRACAINE 4%.

PRODUCT DETAILS

NDC Product Code72934-5010
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationTOPICAL
Effective DateMay 17, 2019
Generic NameNDC 72934- 5010-4 BENZOCAINE 20% / LIDOCAINE 8% / TETRACAINE 4%.

INGREDIENTS (3)

LIDOCAINEActive
Quantity: 8 g in 100 g
Code: 98PI200987
Classification: ACTIB
BENZOCAINEActive
Quantity: 20 g in 100 g
Code: U3RSY48JW5
Classification: ACTIB
TETRACAINEActive
Quantity: 4 g in 100 g
Code: 0619F35CGV
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.